StimuSIL is focused on developing innovative medical devices that utilize proprietary methods for subdermal photobiomodulation, targeting various applications in dermatology and aesthetics. This advanced technique aims to stimulate the skin's biological pathways more effectively and safely by delivering light stimulation beneath the skin's surface. Unlike conventional laser devices that primarily affect the epidermis and suffer from significant energy loss due to the melanin layer, StimuSIL's technology is designed to penetrate this layer, thereby enhancing the efficacy of treatments while minimizing potential losses.

The company is currently advancing its research and development pipeline, with a lead candidate aimed at treating androgenetic alopecia, a prevalent form of hair loss affecting millions. This device seeks to promote regenerative effects by engaging multiple biological pathways beneath the skin. In addition to hair restoration, StimuSIL is exploring various other dermatological and aesthetic applications, including treatments for vitiligo, psoriasis, wrinkles, cellulite, and acne scars. The company is still in the preclinical stage, working towards bringing these innovative solutions to market.

United States

StimuSIL is a medical device company developing proprietary technologies for safer and more effective light therapy. We intend for our products to be used across multiple indications in dermatology and aesthetics. 

We’ve established a team of leading experts in the dermatology, aesthetics, pharmaceuticals, biomedical engineering, and regulatory science fields to lead the research and development across our medical device pipeline.

For more information, visit https://www.stimusil.com/

StimuSIL

Company Details